Liliana Belgioia

Liliana Belgioia is an Associate Professor in the Department of Health Sciences (DISSAL) at the University of Genoa, Italy, specializing in Diagnostic Imaging and Radiotherapy (MEDS-22/A). She serves as Director of the Graduate School for DISSAL and is a member of the Joint Teacher-Student Commission for the School of Medical and Pharmaceutical Sciences, with teaching responsibilities spanning Medicine, Dentistry, and specialized technical health professions.

Her research integrates diagnostic imaging and radiotherapy with a strong oncology focus, particularly investigating tumor progression biomarkers in high-grade glioma using MRI, radiotherapy outcomes in head and neck cancer among frail elderly patients, hypofractionated radiotherapy protocols for vulnerable populations, metastasis-directed therapy in prostate cancer, and advanced brachytherapy techniques for cervical cancer. This work bridges clinical practice with technical innovation in radiation oncology.

Recent 2024 publications reveal a consistent emphasis on optimizing cancer treatment for high-risk populations through imaging biomarkers and tailored radiotherapy approaches. Key themes include MRI-based differentiation of true tumor progression from pseudoprogression, frailty assessment in geriatric radiotherapy, abbreviated treatment schedules for frail patients, imaging modality impacts on prostate cancer outcomes, and adaptive brachytherapy in cervical cancer management.

No scientific awards were mentioned in the provided text.

Professor Belgioia supervises graduate education across multiple programs including Medicine, Dentistry, and Technical Health Professions, teaching core courses in Applied Medical Technical Sciences, Radiotherapy, Diagnostic Imaging, and Radiation Protection. Her multicenter research collaborations indicate involvement in externally funded projects despite no specific grants being documented.

She actively participates in multinational research networks, notably the PRECISE-MDT prostate cancer study and multicenter cervical cancer radiotherapy analysis, demonstrating leadership in advancing evidence-based radiation oncology practices through collaborative clinical investigations.